Clinical Trial
Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU
- PMID: 329981
Item in Clipboard
Clinical Trial
Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU
Cancer Treat Rep.
1977 Aug.
Abstract
Thirty patients with disseminated melanoma were treated with DTIC (250 mg/m2 for 5 consecutive days every 3 weeks), methyl-CCNU (175 mg/m2 orally every 6 weeks), and vincristine (1.4 mg/m2 weekly x 6 and then every 3 weeks). Seven patients died within 3 weeks of the start of chemotherapy. There was a 30% response rate (seven partial and two complete remissions) for all patients and a 39% response for evaluable patients. The median survival was 45 and 18 weeks respectively for responders versus non-responders and 22 weeks for all evaluable patients.
Similar articles
-
Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):451-3. Cancer Chemother Rep. 1975. PMID: 1097102 Clinical Trial. No abstract available.
-
DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).Cancer Treat Rep. 1976 May;60(5):601-9. Cancer Treat Rep. 1976. PMID: 991149 Clinical Trial.
-
[Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma].Vopr Onkol. 1981;27(4):16-21. Vopr Onkol. 1981. PMID: 7015692 Clinical Trial. Russian.
-
DTIC (NSC-45388) in malignant melanoma: a perspective.Cancer Treat Rep. 1976 Feb;60(2):165-76. Cancer Treat Rep. 1976. PMID: 769969 Review. No abstract available.
-
Methyl-CCNU inclinical cancer therapy.Cancer Treat Rev. 1974 Dec;1(4):251-69. doi: 10.1016/s0305-7372(74)80018-6. Cancer Treat Rev. 1974. PMID: 4377543 Review. No abstract available.
Cited by
-
Vindesine. A short review of preclinical and first clinical data.Cancer Chemother Pharmacol. 1979;2(4):229-32. doi: 10.1007/BF00257185. Cancer Chemother Pharmacol. 1979. PMID: 455579 No abstract available.
-
Combined modality therapy of malignant melanoma.World J Surg. 1979 Jul 30;3(3):329-43. doi: 10.1007/BF01556586. World J Surg. 1979. PMID: 382647 Review. No abstract available.
-
Vindesine as a single agent in the treatment of advanced malignant melanoma.Cancer Chemother Pharmacol. 1979;2(4):257-60. doi: 10.1007/BF00257190. Cancer Chemother Pharmacol. 1979. PMID: 455584
-
Chemotherapy of malignant melanoma.World J Surg. 1979 Jul 30;3(3):321-8. doi: 10.1007/BF01556584. World J Surg. 1979. PMID: 382646 Review. No abstract available.